Fa-Au
Fa-Au is a TrxR inhibitor. Fa-Au downregulates GPX4, induces oxidative stress, mitochondria-associated ferroptosis (ferroptosis) and immunogenic cell death. Fa-Au induces ROS production in hepatoma cells. Fa-Au remodels the tumor immune microenvironment via M1 macrophage polarization, dendritic cell maturation, CD8+ T cell activation and reduction of regulatory T cells. Fa-Au induces an anti-tumor immune feedback loop through the IFNγ/STAT1/SLC7A11 axis. Fa-Au inhibits tumor growth. Fa-Au is applicable to hepatocellular carcinoma-related research.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C64H70AuF6N4O12P
- 分子量:1429.19
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
|
STAT1 |
GPX4 |
Fa-Au (Compound 8) (72 h) potently inhibits the proliferation of HepG2 and Hepa 1-6 hepatocellular carcinoma cells, with IC50 values of 0.48 μM and 0.69 μM respectively after 72 h of incubation[1].
Fa-Au (0.5-2 μM; 24 h) inhibits TrxR activity in HepG2 hepatocellular carcinoma cells in a concentration-dependent manner in vitro[1].
Fa-Au (2 μM; 6 h) induces ROS production in HepG2 hepatocellular carcinoma cells, and this effect is reversed by 6 h pretreatment with the ROS scavenger NAC (HY-B0215)[1].
Fa-Au (0.5-2 μM) induces ROS-mediated endoplasmic reticulum stress in HepG2 hepatocellular carcinoma cells, which is evidenced by concentration-dependent Ca2+ release and upregulation of key ERS markers, and this effect is reversed by pretreatment with NAC[1].
Fa-Au (0-10 μM) induces ferroptosis in HepG2 hepatocellular carcinoma cells via lipid peroxide accumulation, mitochondrial damage, and downregulation of GPX4 and SLC7A11[1].
Fa-Au (2 μM) induces immunogenic cell death in HepG2 hepatocellular carcinoma cells, which is characterized by CRT exposure, HMGB1 release, reduced intracellular ATP levels, and altered expression of ICD-related proteins[1].
Treatment of HepG2 hepatocellular carcinoma cells with Fa-Au (2 μM; 24 h) induces significant changes in the expression of genes associated with oxidative stress and immune response pathways[1].
IFN-γ enhances Fa-Au-induced ferroptosis in HepG2 hepatocellular carcinoma cells via the IFN-γ/STAT1/SLC7A11 axis[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Fa-Au inhibits the proliferation and migration of HepG2 liver cancer cells in an implantable zebrafish tumor model[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 (male, 3-5 weeks old)[1]
-
Dosage:2.5 mg/kg
-
Administration:i.p.; every two days
-
Result:Significantly suppressed tumor growth, with lower tumor weight and smaller tumor volume than both the model group and oxaliplatin group.
Caused no significant body weight changes, and histopathological examination of major organs showed no obvious toxicity.
Increased apoptosis, elevated ROS levels, upregulated ATF-4 expression, downregulated GPX4 expression, increased CRT exposure, and increased HMGB1 release in tumors.
Significantly increased tumor infiltration of CD4+ T cells, CD8+ T cells, and CD86+ immune cells.
Markedly reduced the proportion of immunosuppressive Tregs (CD4+ and Foxp3+) in tumor tissues.
化学情報
-
分子量 1429.19
-
分子式 C64H70AuF6N4O12P
-
SMILES
COC1=CC=C(C2=C(C3=CC=C(OC)C=C3)N(CCCOC(/C=C/C4=CC=C(O)C(OC)=C4)=O)C([Au+]C5N(CCCOC(/C=C/C6=CC=C(O)C(OC)=C6)=O)C(C7=CC=C(OC)C=C7)=C(C8=CC=C(OC)C=C8)N5CC)N2CC)C=C1.F[P-](F)(F)(F)(F)F
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Fa-Au 関連分類
HY-183554 関連分類
Powered by Bioz